Trial Profile
A Single-dose, Randomized, 3-period, Crossover Study to Evaluate the Relative Bioavailability of BCX4161 Formulated as a Soft Gelatin Capsule to BCX4161 Formulated as a Hard Gelatin Capsule and the Effect of Food on BCX4161 Pharmacokinetics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2014
Price :
$35
*
At a glance
- Drugs Avoralstat (Primary)
- Indications Hereditary angioedema
- Focus Pharmacokinetics
- Sponsors BioCryst Pharmaceuticals
- 14 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 05 May 2014 New trial record